TORONTO — Organigram Global Inc. has signed a deal to buy Aurora Cannabis Inc. in an agreement that values the company at $561 million, after a hostile offer from Curaleaf was rebuffed earlier this year.
Organigram CEO James Yamanaka says the transaction is a defining step in the company’s strategy to build a disciplined, global cannabis leader.
Under the offer, Aurora shareholders have the option to receive $7.80 per share in cash, 5.8626 Organigram shares per share or a combination. The total cash available is capped at $253.6 million, while the number of shares available under the offer is limited to 205.8 million.
Aurora executive chair and CEO Miguel Martin says the offer is the result of a robust strategic review process and delivers compelling value.
The friendly deal comes after Curaleaf Holdings Inc. made a hostile offer for Aurora earlier this year.
Stamford, Conn.-based Curaleaf made an offer valued at US$5 per Aurora share, based on Curaleaf’s Oct. 2 closing share price. The proposal includes 0.4013 Curaleaf shares plus US$1 cash for each Aurora share.
---
This report by The Canadian Press was first published Nov. 3, 2026.
